Literature DB >> 10545396

Neurofilament and tubulin gene expression in progressive experimental diabetes: failure of synthesis and export by sensory neurons.

J N Scott1, A W Clark, D W Zochodne.   

Abstract

In human and experimental diabetes, the relationship between molecular abnormalities in perikarya of sensory neurons and structural abnormalities in their distal axons is largely unexplored. In this study we examined neurofilament (Nf) and tubulin messenger RNA (mRNA) expression and their incorporation into distal sensory axons during progressive streptozotocin-induced diabetes in rats. After 2 and 6 months of diabetes, we measured mRNA levels of all three Nf subunits, B50 [growth associated protein-43 (GAP-43)] and alpha-tubulin in L4-L6 dorsal root ganglia using Northern analysis. The same animals underwent morphometric studies of myelinated fibres by light microscopy and quantitative analysis of Nf and microtubule numbers and density within sural myelinated and unmyelinated axons. Multifibre in vivo sensory and motor conduction nerve recordings confirmed slowing of conduction velocities in diabetic rats indicating experimental neuropathy. mRNA levels for the three Nf subunits, B50 (GAP-43) and alpha-tubulin were unchanged from controls at 2 months, but were decreased by 26-46% at 6 months. These changes accompanied declines in Nf numbers and densities within large myelinated sensory axons, and Nf numbers in unmyelinated fibres by 6 months. Microtubule numbers and densities were similarly reduced in large myelinated axons, and microtubule numbers reduced in small myelinated and unmyelinated axons in diabetes at 6, but not 2 months. Axonal atrophy was observed in unmyelinated fibres at 6 months. Our findings indicate that decreased mRNA expression of cytoskeletal proteins in sensory neurons accompanies a reduction in their incorporation into distal axons. These changes imply that there is a direct link between pathological changes in the sensory neuron and alterations of its distal branches from experimental diabetes. The changes in gene expression in diabetes are unique and differ from those that develop after axotomy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10545396     DOI: 10.1093/brain/122.11.2109

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  19 in total

1.  Altered time course of mRNA expression of alpha tubulin in the central nervous system of hens treated with diisopropyl phosphorofluoridate (DFP).

Authors:  T V Damodaran; A Abdel-Rahman; M B Abou-Donia
Journal:  Neurochem Res       Date:  2001-01       Impact factor: 3.996

Review 2.  Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration.

Authors:  Rodolphe Perrot; Raphael Berges; Arnaud Bocquet; Joel Eyer
Journal:  Mol Neurobiol       Date:  2008-07-23       Impact factor: 5.590

3.  Phosphodiesterase-5 is a therapeutic target for peripheral neuropathy in diabetic mice.

Authors:  L Wang; M Chopp; A Szalad; Z Liu; M Bolz; F M Alvarez; M Lu; L Zhang; Y Cui; R L Zhang; Z G Zhang
Journal:  Neuroscience       Date:  2011-07-27       Impact factor: 3.590

4.  Degeneration of the Golgi and neuronal loss in dorsal root ganglia in diabetic BioBreeding/Worcester rats.

Authors:  H Kamiya; W Zhang; A A F Sima
Journal:  Diabetologia       Date:  2006-09-20       Impact factor: 10.122

5.  Stable microtubules contribute to cardiac dysfunction in the streptozotocin-induced model of type 1 diabetes in the rat.

Authors:  Holly Shiels; Anthony O'Connell; M Anwar Qureshi; F Christopher Howarth; Ed White; Sarah Calaghan
Journal:  Mol Cell Biochem       Date:  2006-07-13       Impact factor: 3.396

6.  Down regulation of the proliferation and apoptotic pathways in the embryonic brain of diabetic rats.

Authors:  María Sol Kruse; Joaquín Barutta; María Cristina Vega; Héctor Coirini
Journal:  Cell Mol Neurobiol       Date:  2012-03-13       Impact factor: 5.046

7.  Therapeutic efficacy of sonic hedgehog protein in experimental diabetic neuropathy.

Authors:  Nigel A Calcutt; Karen L Allendoerfer; Andrew P Mizisin; Alicia Middlemas; Jason D Freshwater; Monica Burgers; Rigel Ranciato; Jean-Dominique Delcroix; Frederick R Taylor; Renee Shapiro; Kathy Strauch; Henryk Dudek; Thomas M Engber; Alphonse Galdes; Lee L Rubin; David R Tomlinson
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

8.  A model of chronic diabetic polyneuropathy: benefits from intranasal insulin are modified by sex and RAGE deletion.

Authors:  Cristiane L de la Hoz; Chu Cheng; Paul Fernyhough; Douglas W Zochodne
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-02-21       Impact factor: 4.310

9.  Dynamic changes of neuroskeletal proteins in DRGs underlie impaired axonal maturation and progressive axonal degeneration in type 1 diabetes.

Authors:  Hideki Kamiya; Weixian Zhang; Anders A F Sima
Journal:  Exp Diabetes Res       Date:  2009-10-12

Review 10.  Diabetes and the enteric nervous system.

Authors:  B Chandrasekharan; S Srinivasan
Journal:  Neurogastroenterol Motil       Date:  2007-10-17       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.